학술논문
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial
Document Type
Academic Journal
Author
Source
Annals of Oncology. Jan 01, 2018 29(1):112-118
Subject
Language
English
ISSN
0923-7534